These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20470285)

  • 1. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting progression in IgA nephropathy.
    Bartosik LP; Lajoie G; Sugar L; Cattran DC
    Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
    Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
    Ayodele OE; Okpechi IG; Swanepoel CR
    Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.